Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Azitra Inc AZTR

Healthcare Biotechnology
Azitra, Inc. is an early-stage clinical biopharmaceutical company. The Company is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. It has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics... see more

Recent & Breaking News (NYSEAM:AZTR)

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Business Wire March 15, 2024

Azitra, Inc. Announces Closing of Public Offering

Business Wire February 16, 2024

Azitra, Inc. Announces Pricing of Public Offering

Business Wire February 13, 2024

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Business Wire January 16, 2024

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Business Wire January 3, 2024

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Business Wire November 14, 2023

Azitra to Present at the ThinkEquity Conference

Business Wire October 16, 2023

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

PR Newswire August 29, 2023

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

PR Newswire August 14, 2023

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

PR Newswire July 19, 2023

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

PR Newswire July 11, 2023

Azitra, Inc. Announces Closing of Initial Public Offering

PR Newswire June 21, 2023

Azitra, Inc. Announces Pricing of Initial Public Offering

PR Newswire June 15, 2023